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Human ES- and Induced Pluripotent Stem-Derived Cardiomyocytes. A
Comparative Electrophysiological Study
Fernando Lo´pez-Redondo, Junko Kurokawa, Fumimasa Nomura,
Tomoyuki Kaneko, Tomoyo Hamada, Kenji Yasuda, Tetsushi Furukawa.
Tokyo Medical Dental University, Tokyo, Japan.
Special attention is directed to the potential application of human induced
pluripotent stem (iPS) cell-derived cardiomyocytes for cardiac safety pharma-
cology and toxicology with fewer legal and ethical issues. Supply of commer-
cially available products enables many researchers to test the utility in their
own systems. Although variations of electrophysiological properties have
been reported among pluripotent cell lines by classifying cardiac subtypes
into nodal, atrial and ventricular cells, most cells are spontaneously contracting,
which makes difficult to be implicated in adult human hearts. Thus, we sought
objective description on action potential (AP) parameters recorded from
perforated patch-clamped iCell cardiomyocytes (iCell-CMs, AJ/CDI) by sys-
tematically comparing with those from human ES-derived cardiomyocytes
(hES-CMs, Cellartis). Mean þ/- SE values of APD50 in iCell-CMs (382 þ/-
38 ms, n=36) were significantly longer than those in hES-CMs (278 þ/-
28 ms n=64), while APD90 in iCell-CMs (1210 þ/- 346 ms, n=36) tended to
be longer than those in hES-CMs (776þ/- 136 ms n=64). As for APD90, despite
of the large sample size, there was no statistical significance between iPS-CM
and hES-CMs. Detailed analysis of the variation by Gaussian fitting revealed
that marked differences in shapes of probability distribution between iPS-
CMs and hES-CMs. Although further studies are necessary to know if the
variation of AP parameters affect drug responses, our data provide important
information for cardiac safety assessments.
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Examining the Causes and Consequences of Calcium Overload in Human
Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Matthew J. Betzenhauser, Serge Sicouri, Vanessa Roach,
Jaqueline A. Treat, Michael Xavier Doss, Charles Antzelevitch.
Masonic Medical Research Laboratory, Utica, NY, USA.
Intracellular calcium overload has been linked to arrhythmias in conditions
such as ischemia reperfusion, heart failure, catecholaminergic polymorphic
ventricular tachycardia and digitalis intoxication. While this link has been
extensively studied at the cellular level using animal models, there is a paucity
of information on the causes and consequences of Ca2þ overload in healthy
human myocytes. With the advent of induced pluripotent stem cell-derived
cardiomyocytes (iPSC-CM), human myocytes are becoming more readily
available. However, it remains unclear if these myocytes faithfully recapitulate
all aspects of adult cardiomyocyte physiology. In order to determine if
iPSC-CM will be a useful platform to study the causes and consequences of
Ca2þ overload, we developed methodology to examine Ca2þ overload in
beating clusters of iPSC-CM and in isolated myocytes. Spontaneous and field
stimulated action potentials were measured with high resistance microelectrodes
in spontaneously beating clusters of iPSC-CM while measuring cluster con-
traction with simultaneous video edge detection. Free intracellular Ca2þ was
measured with fluo-4 and confocal microscopy in beating clusters and in isolated
iPSC-CM. Ca2þ overload was induced in both preparations by treatment with
ouabain (2.5-5 uM or with isoproterenol (1 uM) plus 5.4 mM extracellular
Ca2þ. Bothmaneuvers produced a rise in diastolic Ca2þ aswell as the appearance
of oscillatory action potentials, putative delayed afterdepolarizations and
triggered activityies in beating clusters. These results indicate that iPS-derived
cardiomyocytes provide a useful platform to study the mechanisms of Ca2þ
overload-induced arrhythmias as well as possible treatments. However, given
the spontaneous nature of iPS-derived cardiomyocytes, these cells may more
readily recapitulate the effects ofCa2þ overload on sinoatrial or latent pacemaker
cells.
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Characterization of a Transient Outward KD Current in Hips-Derived
Cardiomyocytes
Jonathan M. Cordeiro, Vladislav V. Nesterenko, Robert J. Goodrow,
Serge Sicouri, Jacqueline A. Treat, Michael X. Doss, Charles Antzelevitch,
Jose´ M. Di Diego.
Masonic Medical Research Laboratory, Utica, NY, USA.
Background: Human induced pluripotent stem cell (hiPS)-cardiomyocytes
can be used to create in vitro models of genetic disease such as Brugada
Syndrome (BrS). Central to the development of BrS is the Ca2þ-independent
transient outward Kþ current (Ito). In this study, we characterized Ito in
single hiPS -cardiomyocytes and determined its functional role in beating
clusters.Methods: Embryoid bodies (EBs) were made from a hiPS cell line reprog-
rammed with Oct4, Nanog, Lin28 and Sox2. Whole cell patch clamp was
used to record Ito in single hiPS cardiomyocytes. Action potential (AP) record-
ings from spontaneously beating clusters (BCs) were made using sharp micro-
electrodes. All recordings were done at 36C.
Results: BCs exhibited spontaneous APs with an average rate of
54.9530.1 bpm and maximum diastolic potential (MDP) of 65.659.3 mV
(n=122). A small phase 1 repolarization which could be blocked by 4-AP
(1 mM) was observed in 6/149 hiPS BCs suggesting the presence of Ito.
Interestingly, in single dissociated hiPS cardiomyocytes, patch clamp analysis
revealed a robust Ito (13.451.79 pA/pF at þ40 mV, n=14) in the majority of
cells studied. Recovery of Ito (at 80 mV) showed a fast and slow phase as
follows: i) 1=271593 ms and 2= 26975103 (n=8 cells). These observations
demonstrate that Ito is present but the slow recovery suggests minimal contri-
bution during the course of an action potential. Mathematical modeling of
APs from hiPSC-CMs confirmed these observations.
Conclusion: There is a disconnect between the presence of Ito in cells and the
absence of phase 1 repolarization in BCs. In BCs the depolarized MDP and fast
spontaneous AP rate suggests negligible contribution of Ito to phase 1 repolar-
ization. Our results point to an important deficiency of hiPSC-CMs in recapit-
ulating the phenotype of adult native myocytes.
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Analysis of Zolpidem-Induced Long Qt Syndrome in Recombinant hERG
Channels and Stem Cell Derived Human Cardiomyocytes
Julian Jehle1, Xiaoping Wan2, Isabelle Deschenes2, Dierk Thomas1,
Eckhard Ficker2.
1Medical University Hospital, Heidelberg, Germany, 2Case Western Reserve
University, Cleveland, OH, USA.
Zolpidem, a short-acting hypnotic drug prescribed to treat insomnia, has been
clinically associated with acquired long QT syndrome (acLQTS) and torsade
de pointes tachyarrhythmias (TdP). Because acLQTS is most often precipi-
tated by a reduction of hERG/IKr currents, we have studiedacute hERG block
by zolpidem in HEK cells using patch clamp recordings. We found that zol-
pidem reduced hERG currents with an IC50 value of 65.55 4.5 mM (n=3-6).
In marked contrast to many other hERG blockers, hERG surface expression
was not impaired on long-term drug exposure. To determine whether zolpi-
dem effects in an expression system are relevant to cardiac electrophysiology,
we studied human stem cell-derived cardiomyocytes (iCells, CDI, Madison,
WI). In human cardiomyocytes, zolpidem prolonged APD90 significantly
from 321.2 5 45.5 ms (n = 9) under control conditions to 375.8 5
55.5 ms (n=9) and 414.1 5 54.8 ms (n=9) in the presence of 10 mM and
30 mM zolpidem, respectively. Because zolpidem produced TdP in combina-
tion with the antiarrhythmic drug amiodarone, we investigated whether both
drug effects were additive. When amiodarone was applied separately,
APD90 prolonged from 287.5 5 30.8 ms (n=8) under control conditions to
349.6 5 50.4 ms, and 403.0 5 59.1 ms (n=8) with 100 nM and 1 mM amio-
darone (n=7), respectively. When amiodarone (100nM) and zolpidem were
co-administered, APD90 was further prolonged from 341.0 5 45.3 ms
(n=8) during amiodarone treatment to 381.3 5 38.1 ms with 10 mM (n =
8) and 450.3 5 50.2 ms with 30 mM zolpidem (n = 8). Taken together, our
results indicate that acute zolpidem administration blocks hERG channels
and induces cardiac action potential changes that are consistent with clinically
observed QT prolongation, particularly in patients treated with multiple
medications.
Primary Transporters & Exchangers
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Time Resolved FRET in the SR Ca-ATPase
Joseph M. Autry, Suzanne Haydon, Simon J. Gruber, Kurt C. Peterson,
Bengt Svensson, David D. Thomas.
University of Minnesota, Minneapolis, MN, USA.
We have detected structural dynamics of the sarcoplasmic reticulum
Ca-ATPase (SERCA) using time-resolved fluorescence spectroscopy. The
Ca-ATPase from fast-twitch skeletal muscle (SERCA1a isoform) was labeled
with cyan fluorescent protein (CFP) at the N-terminus in the actuator domain
(A) and fluorescein isothiocyanate (FITC) at Lys-515 in the nucleotide-
binding domain (N). Time-resolved FRET was detected between CFP (donor
in A domain) and FITC (acceptor in N domain) for SERCA in ligand-
stabilized states, including calcium-free (E2), calcium-bound (E1), and
actively-cycling phosphoenzyme (EP). Lifetime fitting and molecular model-
ing were used to interpret fluorescence decays, thereby identifying a dynamic
distribution of structural states within the cytoplasmic headpiece of SERCA
Monday, February 4, 2013 299a(i.e., A-N interdomain distance). FRET results were compared to distance
predictions from x-ray crystallography. We propose a structural mechanism
for ligand activation of SERCA. Acknowledgments: Spectroscopy was per-
formed in the Biophysical Spectroscopy Center at the University of Minnesota,
with assistance from Fluorescence Innovations, Inc. (Gregory Gillispie, Presi-
dent). This work was funded by NIH grants to DDT (R01 GM27906, P30
AR0507220, T32 AR007612).
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Screening for SERCA Activators using a High-throughput Time-Resolved
FRET Assay
Ji Li1, Holly Langer1, Kurt C. Peterson2, Joseph M. Muretta1,
Gregory D. Gillispie1, Razvan L. Cornea1, David D. Thomas1.
1University of Minnesota, Minneapolis, MN, USA, 2Fluorescence
Innovations, Inc., Minneapolis, MN, USA.
We used a prototype time-resolved fluorescence lifetime microplate reader to
carry out a high-throughput screen designed to identify compounds that inter-
act with the sarcoplasmic reticulum calcium ATPase (SERCA). SERCA is
essential for the Ca homeostasis in many cell types. Insufficient SERCA activ-
ity leads to cardiovascular disease, muscular dystrophy, skin disease, and
diabetes. Our goal is to discover activators of SERCA that can be developed
into drugs to treat diseases in which Ca transport is deficient. The fluorescence
lifetime plate reader was made possible by our recent development of fast
time-resolved fluorescence by direct waveform recording, which achieves
105 higher throughput than the conventional single-photon counting technol-
ogy. using this plate reader, we detected fluorescence resonance energy trans-
fer (FRET) between IAEDANS-labeled SERCA and nucleotide analog
TNPADP in native sarcoplasmic reticulum membranes. This assay was de-
signed to detect compounds that interact with SERCA and modify either the
enzyme’s structure or the binding affinity of TNP-ADP. Initial hit compounds
were further analyzed in functional assays. Upon screening a small (1300 com-
pound) library, we determined that the time-resolved microplate reader has at
least 10x higher precision than a conventional intensity-based microplate
reader, raising the quality index (z’) of our assay from marginal, in the inten-
sity reader, to excellent. A 384-well plate is read with high precision in 2 min,
which allows screening of thousands of compounds/day. An important advan-
tage of the time-resolved fluorescence measurement is that it provides detailed
structural information, thus enabling discovery of multiple classes of com-
pounds during the primary screen.
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In-Cell FRET as a Tool to Develop SERCA Activators for Drug or Gene
Therapy
Simon J. Gruber1, Kurt C. Peterson1, Bengt Svensson1, Seth L. Robia2,
David D. Thomas1.
1University of Minnesota, Minneapolis, MN, USA, 2Loyola University,
Chicago, IL, USA.
We are using in-cell FRET methods (Photobleaching, FLIM, time-resolved
FRET in a plate reader) to study the relationships among structure, dynamics,
and function of the sarcoplasmic reticulum Ca-ATPase (SERCA) and its
cardiac regulator phospholamban (PLB), with the goal of designing activators
of SERCA for treatment of heart failure (HF) and muscular dystrophy (MD).
Ca2þ drives muscle contraction, and relaxation is accomplished by the seques-
tration of Ca2þ by the sarcoplasmic reticulum Ca-ATPase (SERCA), which is
inhibited by phospholamban at submicromolar [Ca2þ] in cardiac muscle.
SERCA activity is frequently reduced in HF, and many current therapeutic
strategies aim to increase cardiac Ca2þ cycling activity. We are designing
LOF-PLB mutants (PLBM) that can compete with WT-PLB (PLBW) and
thus relieve SERCA inhibition. Our ideal mutant is partial loss-of-function,
binds tightly to SERCA2a, and remains phosphorylatable via b-adrenergic
pathways. The effects of PLBM on Ca-ATPase activity and FRET are measured
to determine the mutant’s ability to compete with PLBW, both physically and
functionally. Optimal LOF mutants are being tested in a rat model of heart
failure.
In addition to this SERCA-PLB FRET competition assay, we are using
SERCA2a labelled with two different fluorescent probes (GFP and RFP) to
screen for small molecule activators of SERCA in living cells. Time-
resolved FRETmeasurements of RFP-GFP-SERCA2a in 96- or 384-well plates
have shown the extraordinary precision and sensitivity necessary to probe
SERCA’s structure-function relationship. New drug screening efforts are active
and small molecules from previous screens are being developed as promising
drugs for HF therapy (collaboration with Celladon, Inc.). Many of these drugs
are direct SERCA activators and are being investigated for their ability to
rescue the muscular dystrophy phenotype in dystrophic mice.1531-Pos Board B423
EPR Detects Changes in the Transmembrane Region of the SERCA-
Phospholamban Complex upon Ser16 Phosphorylation
Zachary M. James, Jesse E. McCaffrey, Christine B. Karim,
David D. Thomas.
University of Minnesota, Minneapolis, MN, USA.
We have used site-directed spin labeling and electron paramagnetic resonance
(EPR) spectroscopy to investigate the effects of Ser16 phosphorylation on
phospholamban’s interaction with the sarcoplasmic reticulum Ca-ATPase
(SERCA). Muscle contraction is signaled by the release of Ca from the sarco-
plasmic reticulum (SR), while SERCA mediates muscle relaxation by actively
pumping Ca back into the SR lumen. Cardiac SERCA is regulated by phospho-
lamban (PLB), a single-pass transmembrane protein that inhibits the Ca pump
unless phosphorylated at Ser16.
We have shown that Ser16 phosphorylation does not dissociate PLB from
SERCA to relieve inhibition, but instead induces a structural change in
PLB’s transmembrane (TM) helix that restores SERCA Ca sensitivity. To
characterize this change, we have attached spin labels along the TM helix
and performed EPR accessibility measurements to determine the effects of
Ser16 phosphorylation on TM helix topology within the regulatory complex.
Our results show that upon phosphorylation, the TM helix undergoes a vertical
shift that could break inhibitory interactions between SERCA and PLB. Com-
plementary ongoing studies employ these spin-labeled PLB constructs to deter-
mine changes in (a) the orientation of PLB and (b) distances to probes on
SERCA, with the goal of obtaining a detailed structural model for the regula-
tory transitions within the SERCA-PLB complex.
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Orientation of Phospholamban in Lipid Bicelles Detected by Electron
Paramagnetic Resonance
JesseE.McCaffrey, ZacharyM. James,ChristineB.Karim,DavidD.Thomas.
University of Minnesota: Twin Cities, Minneapolis, MN, USA.
We have used electron paramagnetic resonance (EPR) to probe the structural
dynamics of the integral membrane protein phospholamban (PLB), as a function
of phosphorylation and addition of its regulatory target, the sarcoplasmic retic-
ulum calcium ATPase (SERCA). We found previously that PLB remains bound
to SERCA after phosphorylation, suggesting that a structural transition within
the SERCA-PLB complex is responsible for relief of inhibition. Our current
goal is to elucidate this mechanism through orientation and accessibility
EPR, in order to support rational design of therapies to improve calcium
transport in muscle cells. We used the monomeric mutant AFA-PLB,
with the rigid electron spin label TOAC in-
corporated within the transmembrane
domain, and reconstituted the protein in
lipid bicelles and vesicles. EPR showed
that the accessibilities of PLB spin labels
to paramagnetic relaxation agents changed
upon phosphorylation, indicating vertical
(parallel to the membrane normal) move-
ment of PLB. EPR on aligned bicelles
showed that PLB changes its tilt relative
to the membrane upon phosphorylation.
Results will also be reported on structural
changes in the presence of SERCA. This
work was funded by grants from NIH
(R01 GM27906 and T32 AR007612).1533-Pos Board B425
Probing Cardiac Membrane Proteins with Fluorescence Resonance
Energy Transfer
Xiaoqiong Dong, Ji Li, Christine B. Karim, David D. Thomas.
University of Minnesota, Minneapolis, MN, USA.
We have used time-resolved fluorescence resonance energy transfer (TR-
FRET) to study the structural basis of regulation of sarcoplasmic reticulum
Ca2þ ATPase (SERCA) by a single-pass transmembrane protein, phospholam-
ban (PLB). The most prominent feature of heart failure is calcium mishandling,
which is largely due to impaired activity of sarcoplasmic reticulum calcium
ATPase (SERCA), which actively transports Ca2þ from cytosol into the SR
to relax the muscle. Unphosphorylated phospholamban inhibits SERCA by
decreasing its apparent Ca2þ affinity. This inhibition can be relieved by either
micromolar Ca2þ or by phosphorylation of PLB. The structural basis for relief
of inhibition remains controversial. Cross-linking studies support the canonical
dissociation model. However, recent EPR, NMR and FRET studies support
the subunit model, in which subtle structural rearrangements are required to
